ClinicalTrialsFinder
RecruitingNot ApplicableNCT06351085

Enhancing Lung Cancer Screening Through Human-Centered Intervention

Sponsor

University of California, Davis

Enrollment

2,869 participants

Start Date

Nov 10, 2022

Study Type

INTERVENTIONAL

Conditions

Lung Cancer

Summary

The purpose of this study is to further understand the factors involved in increasing lung cancer screening.

Eligibility

Min Age: 50 YearsMax Age: 80 Years

Inclusion Criteria5

  • Interviews:
  • UC Davis Health Systems (UCDHS) primary care providers and clinic staff who provide services to patients ages 50-80.
  • Patients who are eligible for lung cancer screening.
  • Screening Intervention:
  • \- Patients ages 50-80 who have a history of smoking per review of their electronic medical record and who receive care at the following UCDH ambulatory care clinics: Ellison Ambulatory Care Clinic; Elk Grove; Midtown.

Exclusion Criteria7

  • Interviews:
  • Non-consenting patients and patients who do not speak English or Spanish
  • Patients aged 49 and younger
  • Non UCDHS primary care providers and clinic staff
  • Screening Intervention:
  • UCDHS patients who have already received Lung Cancer Screening
  • Patients with existing Cancer diagnosis

Interventions

BEHAVIORALPre-Visit Planner

The study is comparing the implementation of a Pre-Visit Planner to go through the shared decision making process.

BEHAVIORALPre-Visit Planner + MyChart

The study is comparing the implementation of a Pre-Visit Planner to go through the shared decision making process as well as testing if watching educational videos about the Lung Cancer Screening (LCS) process prior to talking to an LVN will help with LCS uptake.

Locations(1)

University of California, Davis

Sacramento, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06351085

Related Trials

A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies

NCT046786483 locations

Virtual Agent Feasibility in Oncology Patients (NTT Data)

NCT066820131 location

Study of Novel Treatment Combinations in Patients With Lung Cancer

NCT05633667100 locations

Lung Cancer Screening in HIgh Risk nonsmokErs by Artificial inteLligence Device

NCT062954971 location

Rhomboid Intercostal Block vs Erector Spinae Block

NCT070406181 location